BREAKOUT STOCK SELL ALERT ACRS - Aclaris Therapeutics, Inc. - Common Stock Initial Alert Price: $3.46 Price High: $19.80 % Gains/Losses: 472.25% (+450% More Than Expected)
ACRS topped out at $19.80 in Today's Trading Session providing a 454% Return on our Initial Trade Alert from Dec. 1st when the stock once only $3.46. This comes after the company announced that its ATI-450 drug candidate demonstrated "durable clinical activity" in a phase 2a trial in patients with moderate to severe rheumatoid arthritis over a 12-week period. We are seeing signals of Profit-Taking/Consolidation from today's run, so we suggest staying on high-alert watching this stock moving forward, as we will be adding it to our watchlist for another potential re-entry after consolidation completes. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
@vinlee2508, The stock did retest and surpass the $19.90's as we expected but as you can see it came back down a little. I will give you a more thorough outlook after Market Opens because we find that making calls before open can cause you to make terrible calls.
spiritedPie14309
⋅
Did the news really fuel this stock that high?
If this is all by retail investors, they're crazy to jump bandwagon after seeing 2x in a day.
MyMIWallet
⋅
@spiritedPie14309, The stock was already up +100% around the 28th of Dec. We initially announced this alert on Dec. 1st.